IP Library Granted Patent US 11,307,146
Granted Patent B2
US 11,307,146 · App. 15/661,696 · Granted Apr 19, 2022

Systems and methods for detection of chemtiluminescent reactions

Inventors: Richard C. Willson (Houston, TX); Jinsu Kim (Houston, TX); Binh V. Vu (Houston, TX); Olga Patricia Vázquez Villegas (Monterrey, MX); Federico Augusto Ruiz Ruiz (Monterrey, MX); Marco Antonio Rito Palomares (Monterrey, MX)
Assignees: University of Houston System; Instituto Tecnológico y de Estudios Superiores de Monterrey
G01N21/76C12Q1/26G01N33/62G01N33/66G01N33/70G01N2021/755G01N2800/042
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,307,146
App. No.
15/661,696
Granted
Apr 19, 2022
Kind
B2
Abstract

Methods, devices and kit for analyzing a sample comprising 1,5-anhydroglucitol and a first analyte via one or more chemiluminescent reactions. Certain embodiments include measuring a first light response resulting from a first chemiluminescent reaction and measuring a second light response resulting from a second chemiluminescent reaction. Certain embodiments also include comparing the first light response to the second light response to determine a ratio of 1,5-anhydroglucitol and the first analyte.

Claims (24)

1. A method for analyzing a sample, the method comprising:

(a) obtaining a sample comprising 1,5-anhydroglucitol and a first analyte;

(b) adding glucose oxidase to the sample, wherein the glucose oxidase causes a first chemiluminescent reaction with the sample;

(c) measuring photons from a first light response resulting from the first chemiluminescent reaction;

(d) adding pyranose oxidase to the sample, wherein:

the pyranose oxidase is sequentially added to the sample after glucose oxidase is added to the sample; and

the pyranose oxidase causes a second chemiluminescent reaction with the sample;

(e) measuring photons from a second light response resulting from the second chemiluminescent reaction; and

(f) calculating a ratio of 1,5-anhydroglucitol and the first analyte based on the measured photons from the first light response to the photons from the second light response, wherein:

measuring photons from the first light response resulting from the first chemiluminescent reaction and measuring photons from the second light response resulting from the second chemiluminescent reaction comprises measuring photons with a light detector; and

comparing the photons from the first light response to the photons from the second light response to calculate a ratio of 1,5-anhydroglucitol and the first analyte comprises transmitting data to a computer processor.

2. The method of claim 1 wherein the sample comprises saliva.

3. The method of claim 1 wherein the sample comprises urine.

4. The method of claim 1 wherein the sample comprises blood.

5. The method of claim 1 wherein the sample comprises interstitial fluid.

6. The method of claim 1 wherein the first analyte is glucose, L-sorbose, D-xylose, D-galactose, glucono-δ-lactone, urea, creatinine, or creatine.

7. The method of claim 1 wherein the light detector is selected from the group consisting of a charged coupled device (CCD), avalanche diode, multi-pixel photon counter (MPPC), silicon photomultiplier (SiPMT), complementary metal-oxide-semiconductor (CMOS) sensor, scientific CMOS (sCMOS) sensor, photomultiplier tube (PMT), photodiode, camera, cellular phone camera, web camera, and smart watch camera.

8. The method of claim 1 wherein the glucose oxidase and the pyranose oxidase are added to the sample via a microfluidic device.

9. The method of claim 1 further comprising accessing a lookup table with the computer processor.

10. The method of claim 9 wherein the lookup table comprises an indication of a physiological condition.

11. The method of claim 10 wherein the physiological condition is related to an insulin level of a person from whom the sample was obtained.

12. The method of claim 1 further comprising normalizing the ratio based on a measurement of a marker in the sample.

13. The method of claim 12 wherein the marker is urea, creatinine, creatine, human serum albumin, or hemoglobin.

14. The method of claim 13 wherein the sample comprises urine, blood or saliva.

Assignments (3)
CONFIRMATORY LICENSE Recorded Feb 27, 2025
From: UNIVERSITY OF HOUSTON
To: NATIONAL SCIENCE FOUNDATION
Reel/Frame 070350/0281 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2018
From: VÁZQUEZ VILLEGAS, OLGA PATRICIA; RUIZ RUIZ, FEDERICO AUGUSTO; RITO PALOMARES, MARCO ANTONIO
To: INSTITUTO TECNOLÓGICO Y DE ESTUDIOS SUPERIORES DE MONTERREY
Reel/Frame 044535/0775 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 4, 2018
From: WILLSON, RICHARD C.; KIM, JINSU; VU, BINH V.
To: UNIVERSITY OF HOUSTON SYSTEM
Reel/Frame 044536/0233 →
Continuity (2)
Provisional Application 62368516 · Jul 29, 2016
Related Publication 20180031484A1 · Feb 1, 2018